IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Recurrent Adult Lymphoblastic Lymphoma

University of Washingtonmonoclonal_antibodyPhase 4 / ApprovedActive

BBB

75/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 66/ 100
Competitive Position: 89/ 100

Competitive context

83 Active assets in the Recurrent Adult Lymphoblastic Lymphoma cohort.

Asset / Sponsor	Phase	Rating
Cladribine Fifth Affiliated Hospital, Sun Yat-Sen University	Phase 4	BBB
ASPARAGINASE Therapeutic Advances in Childhood Leukemia Consortium	Phase 4	BBB
MERCAPTOPURINE ANHYDROUS City of Hope Medical Center	Phase 4	BBB
VINDESINE University Hospital Muenster	Phase 4	BBB
CYCLOSPORIN A City of Hope Medical Center	Phase 2	BBB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant

BBB

Indicative ·

78 / 100

View asset →

Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant

BBB

Indicative ·

76 / 100

View asset →

Recurrent Adult Diffuse Mixed Cell LymphomaDormant

BBB